ERBB2 and breast carcinoma: Among the 784 enrolled breast cancer patients, 235 (30.0%) were classified as luminal A subtype, 368 (46.9%) were luminal B subtype, 108 (13.8%) were HER2 subtype, and 73 (9.3%) were TNBC subtype.